Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abby J Cooper

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|September 28, 2011
Nucleoside optimization for RNAi: a high-throughput platformGabor Butora, Denise M Kenski, Abby J Cooper, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
siRNA-optimized Modifications for Enhanced In Vivo ActivityDenise M Kenski, Gabor Butora, Aarron T Willingham, et al.
Nucleic Acids Research|November 18, 2009
Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivoDenise M Kenski, Abby J Cooper, Jenny J Li, et al.
Plos One|March 12, 2014
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteriaKwan-Ki Hwang, Ashley M Trama, Daniel M Kozink, et al.
The Journal of Clinical Investigation|March 12, 2014
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1Mattia Bonsignori, Kevin Wiehe, Sebastian K Grimm, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|September 28, 2011
Nucleoside optimization for RNAi: a high-throughput platformGabor Butora, Denise M Kenski, Abby J Cooper, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
siRNA-optimized Modifications for Enhanced In Vivo ActivityDenise M Kenski, Gabor Butora, Aarron T Willingham, et al.
Nucleic Acids Research|November 18, 2009
Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivoDenise M Kenski, Abby J Cooper, Jenny J Li, et al.
Plos One|March 12, 2014
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteriaKwan-Ki Hwang, Ashley M Trama, Daniel M Kozink, et al.
The Journal of Clinical Investigation|March 12, 2014
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1Mattia Bonsignori, Kevin Wiehe, Sebastian K Grimm, et al.
Pageof 1